Clinical trial
A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema…
NCT00336323 · Jaeb Center for Health Research, Other · Completed
Key facts
| NCT number | NCT00336323 |
|---|---|
| Title | A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) |
| Official title | A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) |
| Acronym | Bevacizumab |
| Lead sponsor | Jaeb Center for Health Research, Other |
| Collaborators | National Eye Institute (NEI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Retinopathy |
| Intervention type | Drug, Procedure |
| Interventions | Laser Photocoagulation, Bevacizumab |
| Enrollment | 121 |
| Start date | Jun 1, 2006 |
| Primary completion | Nov 1, 2006 |
| Completion | Feb 1, 2008 |
| First posted | Jun 13, 2006 |
| Last update posted | Aug 26, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: